Jeremiah (Jake) was born and raised in New Hampshire. He completed his undergraduate (B.S.) degree in Microbiology at the University of New Hampshire (UNH) in Durham, NH and his doctorate (Ph.D.) degree in Pharmacology and Toxicology at Dartmouth College in Hanover, NH in the lab of John Hwa, M.B.B.S., Ph.D., focusing on the structural and functional characterization of the human prostacyclin (hIP) receptor and naturally-occurring variants. Afterward, Jake ventured north to the easternmost province of Canada, where he attended medical school at Memorial University of Newfoundland (MUN) in the provincial capital of St. John’s. He returned to New England and spent a number of years in Connecticut, where he conducted postdoctoral research at Yale University and the Yale Cardiovascular Research Center (YCVRC) in New Haven, CT, as well as worked as a Scientific Writer and Editor at the Jackson Laboratory for Genomic Medicine (JAX-GM) in Farmington, CT before going on to complete his Internal Medicine residency training and an additional year as Chief Resident at Yale-New Haven Medical Center and Yale-Waterbury Hospital in New Haven and Waterbury, CT. He is currently a fellow in the Division of Endocrinology, Metabolism and Lipid Research at Washington University in St. Louis.
Prostanoids, diabetes and diabetes-related cardiovascular disease, obesity